
Share
As scientific research races against time, AI tools like Anthropic’s Claude are emerging as game-changers. Claude’s capabilities in areas such as computational biology and protein analysis are pushing the boundaries of what is possible in life sciences today.
In a world where scientific breakthroughs can mean the difference between life and death, every minute counts. Researchers are increasingly turning to artificial intelligence (AI) to accelerate their work, and one of the most promising tools in this effort is Claude, an advanced AI model developed by Anthropic. Since its launch last October, Claude has been making significant strides in helping scientists across various fields, from computational biology to protein understanding.
Claude for Life Sciences, a suite of connectors and skills designed to enhance scientific collaboration, was introduced last year. Since then, Anthropic has continued to invest heavily in improving Claude's capabilities, particularly with the release of Opus 4.5. This update brings notable advancements in figure interpretation, computational biology, and protein understanding benchmarks. These improvements are a direct result of partnerships with researchers in both academia and industry, ensuring that Claude is tailored to meet the specific needs of scientists.
One of the key initiatives driving this progress is Anthropic's AI for Science program, which provides free API credits to leading researchers working on high-impact scientific projects worldwide. Through this program, scientists have developed custom systems that leverage Claude in innovative ways, going far beyond traditional tasks like literature reviews or coding assistance.
In the labs where Claude is being used, it has become an integral collaborator, working across all stages of the research process. This includes:

One of the most exciting applications of Claude is through Biomni, an agentic AI platform developed by Stanford University. Biomni addresses a significant bottleneck in biological research: the fragmentation of tools. There are hundreds of databases, software packages, and protocols available, and researchers often spend a considerable amount of time selecting from and mastering various platforms. This time could be better spent on running experiments, interpreting data, or pursuing new projects.
Biomni consolidates these resources into a single system, allowing Claude to navigate through them seamlessly. Researchers can give Biomni requests in plain English, and the platform automatically selects the appropriate tools and databases. Biomni is capable of forming hypotheses, designing experimental protocols, and performing analyses across more than 25 biological subfields.
Consider a genome-wide association study (GWAS), which aims to identify genetic variants linked to specific traits or diseases. For instance, perfect pitch-a rare ability where individuals can recognize musical notes without a reference-has a strong genetic basis. Researchers would typically need to analyze data from a very large group of people, some with the ability and others without.
With Biomni, this process becomes more streamlined and efficient. Researchers can input their research questions in plain English, and Biomni will handle the rest. It selects the appropriate tools, forms hypotheses, designs experimental protocols, and performs the necessary analyses. This not only saves time but also ensures that the research is conducted with precision and accuracy.
The integration of AI into scientific research is reshaping how scientists work, leading to faster and more efficient processes, novel insights, and groundbreaking discoveries. Claude and Biomni are at the forefront of this revolution, demonstrating the potential of AI to accelerate progress in fields that have profound implications for human health and well-being.
Tags
Original Sources
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
16 January 2026
133 articles
Related Articles
Related Articles
More Stories